Acute normovolemic hemodilution in cardiac surgery: rationale and design of a multicenter randomized trial
Contemp. clin. trials; 143 (), 2024
BACKGROUND: Minimizing the use of blood component can reduce known and unknown blood transfusion risks, preserve blood bank resources, and decrease healthcare costs. Red Blood Cell (RBC) transfusion is common after cardiac surgery and associated with adverse perioperative outcomes, including mortality. A...